JZP-430 is primarily utilized in the field of pharmaceuticals, where it plays a significant role in the development of treatments for central nervous system disorders. Its application is particularly noted in the research and therapeutic strategies aimed at addressing conditions such as epilepsy and other seizure-related disorders. The compound is studied for its potential to modulate neurological pathways, thereby offering a pathway to more effective management of these conditions. Additionally, JZP-430 is explored for its efficacy in enhancing the quality of life for patients by potentially reducing the frequency and severity of seizures, which is a critical aspect of treatment protocols in neurology.